Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-18T21:45:44.179Z Has data issue: false hasContentIssue false
  • English
  • Français

A novel treatment for patients with hereditary haemorrhagic telangiectasia

Published online by Cambridge University Press:  08 March 2006

T. B. Farnan ,
G. Gallagher  and
C. M. Scally
T. B. Farnan
Affiliation:
Department of Otolaryngology, Antrim Area Hospital, Antrim, Northern Ireland, UK.
G. Gallagher
Affiliation:
Department of Otolaryngology, Antrim Area Hospital, Antrim, Northern Ireland, UK.
C. M. Scally
Affiliation:
Department of Otolaryngology, Antrim Area Hospital, Antrim, Northern Ireland, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by dermal, mucosal, and visceral telangiectases as well as pulmonary and cerebral arteriovenous malformations. Recurrent epistaxis occurs in the majority of patients, and by the very nature of the thin walled vessels involved it is often refractory to conventional forms of treatment. We present the case of an 82-year-old lady with intractable epistaxis secondary to HHT, that was successfully controlled by the application of fibrin glue.

Keywords

TelangiectasiaHereditary HaemorrhagicFibrin Tissue Adhesive
Type
Research Article
Information
The Journal of Laryngology & Otology , Volume 116 , Issue 10 , October 2002 , pp. 849 - 850
Copyright
© Royal Society of Medicine Press Limited 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)